Sanofi

News

Sanofi unveils eczema drug data, as regulators mull label ex...

Sanofi has revealed details of research, which forms the basis of filings to extend the use of its eczema drug Dupixent (dupilumab) so it can be used to treat adolescents.

News

Sanofi to pay $25 million in bribery charges settlement

French pharma giant Sanofi reached a civil settlement with the US Securities and Exchange Commission (SEC) and agreed to pay a multi-million dollar settlement resolving years of bribery inv

News

Sanofi’s rare disease drug Cablivi approved in the EU

The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is

News

Sanofi stockpiles drugs in case of no-deal Brexit

Fears of border delays and complications in a post-Brexit UK have led to the French pharmaceutical company increasing its contingency stockpiles by four weeks to enable a 14-week supply of

News